Intellia Therapeutics, Inc. (NTLA) Insider Ownership

Historic Insider Ownership Trends

As of April 17, 2026, the three largest insider holders of NTLA are Fred E Cohen (Director, 207.45K shares), Edward J Iii Dulac (Evp, Chief Financial Officer, 160.96K shares), James Basta (Evp, General Counsel, 156.79K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Fred E Cohen - 207,453 0 07 Jan, 2026
Edward J Iii Dulac Evp, Chief Financial Officer 160,963 0 03 Mar, 2026
James Basta Evp, General Counsel 156,794 0 03 Mar, 2026
Birgit C Schultes Evp, Chief Scientific Officer 137,733 0 03 Mar, 2026
William J Chase - 134,693 0 22 Aug, 2025
David Lebwohl Evp, Chief Medical Officer 131,192 0 03 Mar, 2026
Eliana Clark Evp, Chief Technical Officer 93,864 0 03 Mar, 2026
Michael P Dube Vp, Chief Accounting Officer 69,527 0 03 Mar, 2026
Glenn Goddard Evp, Chief Financial Officer 69,213 0 05 Mar, 2024
Derek Hicks Evp, Chief Business Officer 59,878 0 07 Jan, 2025
Muna Bhanji - 27,203 0 13 Jun, 2025
Frank Verwiel - 25,948 0 13 Jun, 2025
Jesse Goodman - 24,359 0 02 Jul, 2025
Brian Goff - 23,409 0 13 Jun, 2025
Caroline Dorsa - 12,701 0 16 Jun, 2022
John F Crowley - 11,716 0 16 Jun, 2023
Jean Francois Formela - 7,291 0 16 Jun, 2022

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
01 Mar, 2026 Michael P Dube Common Stock A 17,250 $0.00 69,527 D A
01 Mar, 2026 Edward J Iii Dulac Common Stock A 61,280 $0.00 160,963 D A
01 Mar, 2026 Birgit C Schultes Common Stock A 39,200 $0.00 137,733 D A
01 Mar, 2026 Eliana Clark Common Stock A 7,353 $0.00 94,471 D A
01 Mar, 2026 James Basta Common Stock A 46,080 $0.00 158,005 D A
01 Mar, 2026 David Lebwohl Common Stock A 9,943 $0.00 131,192 D A
02 Mar, 2026 Eliana Clark Common Stock D 607 $13.78 93,864 D S
01 Mar, 2026 David Lebwohl Stock Option (right to buy) A 14,204 $0.00 14,204 D A
01 Mar, 2026 Birgit C Schultes Stock Option (right to buy) A 56,000 $0.00 56,000 D A
01 Mar, 2026 Edward J Iii Dulac Stock Option (right to buy) A 87,543 $0.00 87,543 D A
02 Mar, 2026 James Basta Common Stock D 1,211 $13.78 156,794 D S
01 Mar, 2026 James Basta Stock Option (right to buy) A 65,829 $0.00 65,829 D A
01 Mar, 2026 Eliana Clark Stock Option (right to buy) A 10,505 $0.00 10,505 D A
05 Jan, 2026 Michael P Dube Common Stock D 2,989 $9.21 52,277 D S
05 Jan, 2026 David Lebwohl Common Stock D 11,903 $9.21 121,249 D S
05 Jan, 2026 James Basta Common Stock D 10,397 $9.21 101,528 D S
05 Jan, 2026 Fred E Cohen Common Stock A 150,000 $9.35 207,453 D P
05 Jan, 2026 Birgit C Schultes Common Stock D 8,508 $9.21 98,533 D S
05 Jan, 2026 Eliana Clark Common Stock D 9,515 $9.21 87,118 D S
05 Jan, 2026 Edward J Iii Dulac Common Stock D 6,379 $9.21 99,683 D S